Shares of Quince Therapeutics, Inc. (QNCX) are moving up about 8 percent on Monday morning trading after the company announced the settlement of its outstanding obligations under its loan from the European Investment Bank for a payment of $5.5 million.
The company's shares are currently trading at $0.09 on the Nasdaq, up 8.79 percent. The stock opened at $0.1133. Over the past year, it has traded in a range of $0.08 to $4.55.
The completion of debt settlement resolves critical debt obligations, allowing the company to advance its restructuring and evaluation of strategic alternatives to maximize shareholder value.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.